Latest video from Jen Brea on “Canary In A Coal Mine.” Jen is very sweet in her “Happy Thanksgiving” message in which she brings us up to date on the projected time for next year’s opening of our long-awaited release of the film.
“Canary In A Coal Mine” will tell the story of ME/CFS patients. Funds for the film were amassed in the record-smashing Kickstarter campaign. The original goal was to raise $50,000, and within the given thirty days, well over $200,000 were collected!
What a fantastic statement about the importance of this film now in progress and the impact we are hoping it will have for the world’s sufferers of ME.
Documentary Film Program Provides $1.5 MM In Grant Support to Filmmakers in FY2014
The larger number of projects selected for support by Sundance Institute reflects a funding philosophy designed to embrace both existing and emerging mandates. Films selected include both passionate treatments of human rights issues and contemporary social relevance globally, as well as artful or cinematic documentary films that are compelling, creative, and meaningful for the culture at large. This expansive round has called for a greater number of film awards than ever before, in this case 44 films globally.
Canary in a Coal Mine (Jennifer Brea, U.S.) and others.
A film about life with M.E., the most prevalent and devastating disease your doctor has never heard of.
Watch the trailer for “Canary in a Coal Mine” below:
What is M.E.? And what is the difference between it and CFS?
It is an injury to the Central Nervous System. usually triggered by an infectious disease process, e.g. a virus, or by chemicals over stimulating the immune system. (Some researchers believe that M.E. is only ever caused by a virus. Others have commented that the same symptoms can be caused by chemicals.
M.E. is a multi-system disease, affecting not only the neurological system but also the immune, musculoskeletal, endocrine (hormonal) and cardiovascular systems.
Prognosis is variable depending on how much and which part of the brain has been damaged. Complete pre-illness recovery is rare but possible (around 6% of cases.) Some improvement, even marked improvement (different from full remission) is more likely than complete recovery, although relapses can occur several years after remission. Most cases stabilize at varying degrees of disability. Around 30% of cases are progressive and degenerative and degeneration of end organs may result in death. (One quote of early death rate in M.E. is 10%. This figure includes suicides. Early death from cardiac pathology is put at 2%. Pancreatic failure can also contribute to early death. Symptoms can be multiple and vary from person to person but common symptoms include post-exertional malaise (PEM), cognitive problems (such as short-term memory loss and concentration difficulties), muscle and nerve pain, muscle weakness, noise and light sensitivity, sleep and temperature disturbance, orthostatic intolerance (inability to sustain upright activity e.g. standing, sitting or walking) and sensitivity to certain foods, smells, alcohol, chemicals, light, noise and medicines.
M.E. is not the same as CFS (Chronic Fatigue Syndrome). This is because there are currently 10 different interpretative criteria for CFS, some with a psychiatric and others with an immunological specification. If the CFS criteria used involves damage to the Central Nervous System, then it could well be the same disease as M.E. Other CFS criteria used focus on patients whose fatigue could be of psychiatric origin and this is not M.E.
The name M.E. has a long medical history of being a neurological disease, being classified in neurological textbooks since the 1960s. It is a recognized disease by the WHO (World Health Organization) for at least 3 decades.
The name CFS was created in the 1980s with almost exclusive emphasis on the word ‘fatigue’, leaving out much pathology (structural evidence of disease) and previous physical M.E. research findings. The vagueness of the term CFS is thus attractive to insurance companies, drug companies promoting anti-depressants for fatigue and government departments intent on saving money through benefits, support and research programs. Any illness which has guidelines excluding pathology tends to not be taken seriously by medical and governmental authorities.
Therefore, the term CFS can be harmful as a label to M.E. sufferers because it can exclude pathology. Sometimes, however, researchers and medical staff use the term CFS to mean M.E. So the situation is unacceptably confusing. M.E. is a more specific name implying the pathology which has been found.
Posted in Advocacy, Health Issues, Illness, M.E.
Tagged Canary in a Coal Mine, central nervous system, chronic illness, disease, M.E., multi-system disease, myalgic encephalomyelitis, World Health Organization